InsidersTradesSigma
Track the 沃森生物 stock price and the full management transaction log of the company, a listed equity based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 沃森生物 has recorded 13 public disclosures. Market capitalisation: €19.4bn. The latest transaction was filed on 27 February 2023 (Purchase). Among the most active insiders: 广州盈沃企业管理合伙企业(有限合伙). Every trade is free.
13
Insider Decl.
n/a
Thresholds
€14m
2 ops.
Buy Volume
€62m
11 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 17,259 of 29,062 companies
46.4
score / 100
Value28
Quality65
FCF yld-0.1%
Earn yld0.9%
EV/EBITDA35.5x
ROE2.7%
Gross mgn75%
Net mgn7.4%
Debt/EBITDA0.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 27 February 2023
Declarations13 total
667,600 sharesA股XSHESZSE:173000006349769820
1,968,200 sharesA股XSHESZSE:173000006286409570
77,600 sharesA股XSHESZSE:173000006177297860
53,500 sharesA股XSHESZSE:173000006166610560
13 of 13 declarations
About 沃森生物
沃森生物 is a company in the health and pharmaceutical sector, listed on the XSHE market. It focuses on the research and development of biopharmaceutical products.